# ðŸ” Case & Background  

The methods developed in our laboratory are tailored for **workplace drug testing**, with three distinct analytical approaches designed to address different business needs: **U-DoA, Q-DoA, and OF-DoA**. The purpose of these tests is to determine whether a donorâ€™s biological sample contains one or more prohibited substances that could impair performance or pose safety risks in the workplace. Each sample is screened for multiple analytes simultaneously.  

A **negative result** means that none of the target analytes are detected above the established cutoff levels, whereas a **positive result** indicates that at least one analyte is present at a concentration higher than its threshold.  

### Standard Workflow  
1. Donor samples are collected using specialized collection kits for saliva (Q-DoA and OF-DoA) or urine (U-DoA).  
2. The samples are transported to the laboratory for analysis using **LC-MS/MS (Liquid Chromatography with Tandem Mass Spectrometry)**.  
3. The LC-MS/MS instrument generates detailed measurements of the analytes present.  
4. These results are compiled and presented to a trained technician, who reviews the data and determines whether the sample should be classified as positive or negative.  

This manual evaluation is time-intensive, as the technician must carefully interpret the LC-MS/MS output to confirm whether any analytes exceed the required thresholds. The objective of this project is to **develop a predictive model that can automate this interpretation**, increasing efficiency while maintaining accuracy.  

To fully understand the work done by the technician when evaluating results, it is essential to first explain how LC-MS/MS operates. This technical background will also serve as the foundation for selecting suitable **data preprocessing methods** for the predictive model.  

# ðŸ”¬ LC-MS/MS  

**LC-MS/MS (Liquid Chromatographyâ€“Tandem Mass Spectrometry)** is a powerful analytical technique used to separate, identify, and quantify moleculesâ€”particularly in complex biological samples such as blood, urine, or tissue.  

To help you succeed in this hackathon and achieve the best possible results, we will provide a clear explanation of how the LC-MS/MS method works.  

LC-MS/MS combines two distinct processes:  

- **Liquid Chromatography (LC)** â†’ separates compounds in a mixture based on their chemical properties.  
- **Tandem Mass Spectrometry (MS/MS)** â†’ identifies and quantifies molecules based on their *mass-to-charge ratio (m/z)*.  

In the following sections, we will describe each of these processes in detail and show how the data they generate are used to identify analytes and determine their concentration.  

### âš—ï¸ Liquid Chromatography

Liquid Chromatography is the first phase of the LC-MS/MS process. It is a separation technique where molecules in a biological sample are separated based on their chemical properties before mass spectrometry analysis.

In this method, the liquid mobile phase, which contains the patient sample, flows through the stationary phaseâ€”typically a packed column. As the sample moves through the column, each compound travels at a different speed depending on its chemical affinity for either the mobile or stationary phase. These affinities are determined by the moleculeâ€™s properties, such as *polarity*, *charge*, or *size*.

Because each compound interacts uniquely with the column, they **elute** (exit) at different times. However, the same molecule will consistently elute at the same time, provided the method is consistent. This predictable elution time is referred to as the **retention time**, and for many analytes in our method, the elution window is around **30 seconds**.

In practice, compounds with the same identity will form **peaks** at the same retention time, within a small acceptable variationâ€”typically Â±0.1 secondsâ€”which helps confirm their identity with high confidence.

> **Goal:** Separate molecules in time, so they donâ€™t all enter the mass spectrometer at once, but rather in small, organized groups, where each molecule elutes with its own kind, resulting in clearer, more interpretable signals.

<div align="center">

<img src="images/liquid_chromatography_diagram.png" alt="System Diagram" width="600">

<p><strong>Figure 1.</strong> In this diagram, the compound with lower affinity for the stationary phaseâ€”illustrated in yellowâ€”elutes earlier than the compound with stronger interactions (pink), resulting in distinct retention times.</p>

</div>

### ðŸ” Tandem Mass Spectrometry (MS/MS)

Tandem Mass Spectrometry in LC-MS/MS typically uses a triple quadrupole instrument, consisting of three quadrupoles: **Q1**, **Q2**, and **Q3**. It is called tandem MS because the ions are filtered twiceâ€”once in Q1 and again in Q3.

#### Steps of the Method

- **Ionization**  
  Each compound is ionized by gaining or losing a proton or electron, enabling it to carry a charge. This is necessary because mass spectrometry manipulates charged particles using electric and magnetic fields, and neutral molecules cannot be detected.

- **Q1 (Precursor Ion Selection)**  
  The first quadrupole filters ions based on their mass-to-charge ratio (\(m/z\)), selecting only the compound of interest. This selected ion is called the **precursor ion** because it will be fragmented in the next step.

- **Q2 (Collision-Induced Dissociation, CID)**  
  The precursor ion collides with an inert gas, causing it to fragment into smaller pieces. These fragment ions result from predictable breakages, and each precursor-to-fragment ion transition is represented by the molecular weight of the precursor ion followed by that of the fragment ion (e.g., 141.1 > 124.1).

- **Q3 (Fragment Ion Selection)**  
  The third quadrupole filters the fragment ions based on their \(m/z\), selecting those of interest. Most compounds show two main fragment ions, but this may vary depending on fragment stability and method setup.

- **Detection**  
  The detector counts the number of fragment ions that pass through Q3, converting these counts into an electrical signal. This signal is recorded in real time, producing a chromatogram that represents the ion abundance over time.

This sequential filtering and fragmentation process provides high specificity and sensitivity, allowing accurate identification and quantification of compounds within complex biological samples. 

Think of it as having almost no chance of measuring intensity from another analyte that is not the analyte of interestâ€”one that would elute at exactly the same time, have the same mass-to-charge ratio (Q1), and then under external forces (Q2) fragment into two ions with the exact same mass-to-charge ratios (Q3). This level of specificity effectively eliminates interference from other compounds, ensuring reliable and precise measurements.

<div align="center">

<img src="images/chromatogram.png" alt="System Diagram" width="600">

<p><strong>Figure 2.</strong> Example chromatogram showing relative abundance of detected ions over retention time.</p>

</div>

### Chromatogram and Relative Abundance  

A chromatogram displays the **relative abundance** of ions over time. For each ion (fragment), a separate intensity graph is generated. The Y-axis of each graph shows the signal intensity normalized individually to that ionâ€™s most intense peak, which is scaled to 100%.  

This per-ion normalization allows clear visualization of all fragments, especially since many compounds produce one dominant fragment ion (often near 90% relative abundance) alongside several lesser-abundant fragments that might otherwise be difficult to detect.  

> **Note:** This type of graph is called a **Chromatogram** because the time component arises from the prior chromatographic separation.  
> Instead of visual detection (such as the color-based detection in Figure 1), here we use mass spectrometry to identify compounds based on their mass-to-charge ratio.








